DOI QR코드

DOI QR Code

Discordant Relationships between Systemic Inflammatory Markers and Burden of Oxidative Stress in Patients with Atrial Fibrillation

  • Nam, Jong-Ho (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Park, Kyu-Hwan (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Lee, Jung-Hee (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Lee, Chan-Hee (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Son, Jang-Won (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Kim, Ung (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Park, Jong-Seon (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) ;
  • Shin, Dong-Gu (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center)
  • 투고 : 2017.01.31
  • 심사 : 2017.06.06
  • 발행 : 2017.09.30

초록

Background and Objectives: Oxidative stress (OS) plays an important role in the pathophysiology of atrial fibrillation (AF) by amplifying the inflammatory cascade, wherein augmented inflammation facilitates the atrial electrical remodeling process. Few studies have investigated the possible link between systemic inflammation and OS in AF. Subjects and Methods: A total of 220 consecutive patients with AF (117 patients) or healthy controls (103 patients) were enrolled. Among the 117 AF patients, 65 paroxysmal AF (PaAF) and 52 persistent AF (PeAF) patients were included. The level of 8-iso-prostaglandin $F2{\alpha}$ ($8-iso-PGF2{\alpha}$) was measured as a marker of OS burden. We evaluated the correlations between 3 systemic inflammatory markers, high-sensitivity C-reactive protein (hsCRP), neutrophil to lymphocyte ratio (NLR), and red cell distribution width (RDW), and $8-iso-PGF2{\alpha}$. Results: The $8-iso-PGF2{\alpha}$ concentration in both PaAF and PeAF patients was higher than that of controls (p<0.001 and p=0.024, respectively). The NLR and RDW of PeAF patients were higher than those of both control and PaAF patients (p=0.041 and p=0.031 for NLR, p=0.057 and p=0.031 for RDW, respectively). There were no correlations between specific inflammatory markers and the $8-iso-PGF2{\alpha}$ in AF. The $8-iso-PGF2{\alpha}$ level decreased gradually with an increase in AF duration (p=0.008), contrary to the graded increase in hsCRP. Multiple regression analysis indicated that AF duration persisted as a significant determinant of $8-iso-PGF2{\alpha}$ (${\beta}=-0.249$, p=0.044). Conclusion: Systemic inflammatory marker levels were not proportional to the levels of $8-iso-PGF2{\alpha}$, an OS marker, in AF.

키워드

참고문헌

  1. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263-70. https://doi.org/10.1016/j.jacc.2012.04.063
  2. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135-43. https://doi.org/10.1016/j.ijcard.2006.04.026
  3. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. 3rd ed. Oxford: Oxford Univeristy Press; 1999. p. 936.
  4. Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:1064-70. https://doi.org/10.1111/j.1540-8167.2010.01774.x
  5. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-8. https://doi.org/10.1016/j.jacc.2006.12.042
  6. Kornej J, Reinhardt C, Kosiuk J, et al. Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome. PLoS One 2012;7:e44165. https://doi.org/10.1371/journal.pone.0044165
  7. Uthamalingam S, Patvardhan EA, Subramanian S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011;107:433-8. https://doi.org/10.1016/j.amjcard.2010.09.039
  8. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008;395:27-31. https://doi.org/10.1016/j.cca.2008.04.019
  9. Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T. Usefulness of neutrophil/lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res 2015;46:199-206. https://doi.org/10.1016/j.arcmed.2015.03.011
  10. Canpolat U, Aytemir K, Yorgun H, et al. Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol 2013;112:513-9. https://doi.org/10.1016/j.amjcard.2013.04.015
  11. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91. https://doi.org/10.1016/j.amjcard.2009.09.007
  12. Karavelioglu Y, Karapinar H, Yuksel M, et al. Neutrophil to lymphocyte ratio is predictor of atrial fibrillation recurrence after cardioversion with amiodarone. Clin Appl Thromb Hemost 2015;21:5-9. https://doi.org/10.1177/1076029613518368
  13. Adamsson Eryd S, Borne Y, Melander O, et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014;275:84-92. https://doi.org/10.1111/joim.12143
  14. Liu T, Shao Q, Miao S, et al. Red cell distribution width as a novel, inexpensive marker for paroxysmal atrial fibrillation. Int J Cardiol 2014;171:e52-3. https://doi.org/10.1016/j.ijcard.2013.11.112
  15. Lee KH, Park HW, Cho JG, et al. Red cell distribution width as a novel predictor for clinical outcomes in patients with paroxysmal atrial fibrillation. Europace 2015;17 Suppl 2:ii83-8. https://doi.org/10.1093/europace/euv210
  16. Roberts LJ 2nd, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-13. https://doi.org/10.1016/S0891-5849(99)00264-6
  17. Schwedhelm E, Boger RH. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin Chem Lab Med 2003;41:1552-61.
  18. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-47. https://doi.org/10.1093/eurheartj/ehs253
  19. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52:306-13. https://doi.org/10.1097/FJC.0b013e31817f9398
  20. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-92. https://doi.org/10.1093/eurheartj/ehi350
  21. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007;50:2021-8. https://doi.org/10.1016/j.jacc.2007.06.054
  22. Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009;72:466-7. https://doi.org/10.1016/j.mehy.2008.08.031
  23. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 2003;9:RA225-9.
  24. Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011;124:1107-17. https://doi.org/10.1161/CIRCULATIONAHA.111.029223
  25. Cangemi R, Celestini A, Calvieri C, et al. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 2012;98:1063-6. https://doi.org/10.1136/heartjnl-2012-301952
  26. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.
  27. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80. https://doi.org/10.1161/01.CIR.104.2.174
  28. Kim YM, Guzik TJ, Zhang YH, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005;97:629-36. https://doi.org/10.1161/01.RES.0000183735.09871.61
  29. Il'yasova D, Ivanova A, Morrow JD, Cesari M, Pahor M. Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers 2008;13:41-51. https://doi.org/10.1080/13547500701617708
  30. Korantzopoulos P, Papaioannides D, Galaris D, Kokkoris S. Does C-reactive protein represent an oxidative stress marker in cardiovascular disease? Int J Clin Pract 2003;57:252.

피인용 문헌

  1. Five‐Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation vol.8, pp.17, 2019, https://doi.org/10.1161/jaha.119.013204
  2. Red blood cell distribution width and atrial fibrillation vol.14, pp.13, 2017, https://doi.org/10.2217/bmm-2020-0041